Clinical factors, including All Patient Refined Diagnosis Related Group severity, as predictors of early rehospitalization after COPD exacerbation

Article Page

Abstract

Background: Patients hospitalized for chronic obstructive pulmonary disease (COPD) exacerbations carry a high risk for early rehospitalization. We wished to identify the basic clinical factors associated with a high risk of rehospitalization, and to see how well the standardized All Patient Refined Diagnosis Related Group (APR-DRG) severity of illness (SOI) subclassification predicted rehospitalization if combined with other simple clinical measures.

Methods: We identified adult patients aged ≥40 years discharged from a major hospital in the Southwestern USA with a COPD discharge diagnosis during the study index period (1 October 2009 to 30 September 2010). Patients readmitted within 30 days (“early rehospitalization”) and 90 days (“any rehospitalization”) were each compared with those not rehospitalized. Clinical parameters (including demographics, comorbidities) and recent healthcare utilization were examined for their association with rehospitalization. Factors independently associated with rehospitalization were then combined with the index admission APR-DRG SOI assessment using conditional linear regression to find the best models in terms of the highest C-statistic.

Results: Among 306 patients hospitalized for COPD, 62 (20.3%) had a rehospitalization within 90 days and 28 (9.2%), an early readmission. An APR-DRG SOI subclassification ≥3 was a modest independent predictor of early or any readmission, with adjusted odds ratios ranging from 2.09 to 3.33. Models that combined the APR-DRG SOI subclassification with clinical factors present before the index hospitalization had strong C-statistics of ≥0.80. Good models without the APR-DRG SOI subclassification but including a history of recent hospitalizations before the index hospitalization were also identified.

Conclusions: An APR-DRG SOI subclassification of ≥3 for the index COPD admission is associated with an increased risk of early rehospitalizations, and can be combined with a few historical clinical factors to create strong predictive models for rehospitalization. This study demonstrates that hospitals can use commonly collected clinical information to help identify COPD patients at a high risk of failure after discharge.

Keywords: pulmonary disease, chronic obstructive; lung diseases, obstructive; patient readmission; hospitalization.

Abbreviations: ACE, angiotensin-converting enzyme; APR-DRG, All Patient Refined Diagnosis Related Group; ARB, angiotensin II receptor blocker; CHF, congestive heart failure; CMS, Centers for Medicare and Medicaid; COPD, chronic obstructive pulmonary disease; DRG, Diagnosis Related Group; HMO, health maintenance organization; ICS, inhaled corticosteroid; LAMA, long-acting muscarinic antagonist; NDI, National Death Index; OD, odds ratio; OCS, oral corticosteroid; SABA, short-acting beta-agonist; SAMA, short-acting muscarinic antagonist; SOI, severity of illness

Citation
Roberts MH, Mapel DW, Von Worley A, Beene J. Clinical factors, including the All Patient Refined Diagnosis Related Group severity, as predictors of early rehospitalization after COPD exacerbation. Drugs in Context 2015; 4: 212278. doi: 10.7573/dic.212278 

Copyright
Copyright © 2015 Roberts MH, Mapel DW, Von Worley A, Beene J. Distributed under the terms of the Creative Commons License Deed CC BY NC ND 3.0 which allows anyone to copy, distribute, and transmit the article provided it is properly attributed in the manner specified below. No commercial use without permission.

Correct attribution
Copyright © 2015 Roberts MH, Mapel DW, Von Worley A, Beene J. http://dx.doi.org/10.7573/dic.212278. Published by Drugs in Context under Creative Commons Attributions License Deed CC BY NC ND 3.0.

Article URL
https://www.drugsincontext.com/clinical-factors-including-the-all-patient-refined-diagnosis-related-group-severity-as-predictors-of-early-rehospitalization-after-COPD-exacerbation

Correspondence
Melissa H Roberts, PhD, Senior Research Associate, Lovelace Clinic Foundation, 2309 Renard Place SE, Suite 103, Albuquerque, NM 87106, USA. MRoberts@LCFResearch.org

Provenance
Submitted, externally peer reviewed

Dates
Submitted: 31 January 2015
Accepted, subject to peer review: 6 February 2015
Revised manuscript submitted: 27 February 2015
Publication date: 18 March 2015

Publisher & contact information
Drugs in Context is published by Just Medical Media Ltd
Undermount, Rydal, Ambleside, Cumbria, LA22 9LT, UK
ISSN 1740-4398
Just Medical Media Limited is registered in England Number 6891187
VAT GB 945 1713 22

Julia Savory
Head of Digital Publishing and Submissions Management
julia@justmedicalmedia.com
Tel: +44 (0)1242 910 999

Download free full text PDF